Premium
Treatment of ACE Inhibitor‐Induced Cough
Author(s) -
Luque Carla A.,
Ortiz Mariola Vazquez
Publication year - 1999
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.19.10.804.31563
Subject(s) - medicine , discontinuation , ace inhibitor , theophylline , sulindac , angiotensin converting enzyme , anesthesia , pharmacology , nonsteroidal , blood pressure
Angiotensin‐converting enzyme (ACE) inhibitors are widely administered to treat numerous medical conditions. Although they are generally well tolerated, they are associated with a dry cough that can lead to discontinuation of treatment. Data concerning the frequency, onset, and clinical effects vary among the agents. When discontinuing the ACE inhibitor is not an ideal option, pharmacologic treatment of the cough may be considered, such as cromolyn, baclofen, theophylline, sulindac, and local anesthetics.